Pasture Holdings Ltd. (UUK) Fair Value & Analysis
Healthcare · SG · Market cap 9.9M SGD
Fair value as of: Aug 13, 2026
From 22 valuation models · updated 5 days ago
Share price −1.3% over the past month.
A solid business, screening 15% undervalued on our models.
What matters now
- Our model range runs from 0.0713 SGD (bear) to 0.1013 SGD (bull), base 0.0863 SGD. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 59/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
38‑month range 0.0291 SGD – 0.2380 SGD · fair‑value band 0.0713 SGD – 0.1013 SGD · the 0.0750 SGD price screens below the 0.0863 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Pasture Holdings Ltd. (UUK) currently trades at 0.0750 SGD, while our model-based Fair Value estimate is 0.0863 SGD, implying the stock looks roughly 15.1% undervalued today. The Quality Score stands at 59/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Pasture Holdings Ltd. generated revenue of 9.3M SGD at a net margin of -7.6%. Revenue declined 40.6% year over year. It earns a return on equity of -16.8%. Fundamentals as of Aug 13, 2026
Our scenario range runs from 0.0713 SGD (bear case) to 0.1013 SGD (bull case); at 0.0750 SGD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 61% below its 52-week high and 149% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -7% fair-value upside, at 15%, UUK screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: DCF Models (0.0900 SGD) versus Earnings-Based (0.0300 SGD). Highest evidence: Growth DCF (80).
Notify me when UUK reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 64 · Market factors (momentum, volatility) 37
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Pasture Holdings Ltd. operates as a pharmaceutical products and medical supply company in Japan, Hong Kong, Canada, Singapore, and internationally. The company operates through three segments: Pharmaceutical Wholesale and Drop-Shipment; Masks and Medical Supplies; and Other Services.
Full company description
Pasture Holdings Ltd. operates as a pharmaceutical products and medical supply company in Japan, Hong Kong, Canada, Singapore, and internationally. The company operates through three segments: Pharmaceutical Wholesale and Drop-Shipment; Masks and Medical Supplies; and Other Services. It is involved in the wholesale procurement and transshipment of pharmaceutical and nutraceutical products, such as vaccines and oncology treatments; and backend support of pharmaceutical supplies to international clients' online pharmacy businesses. The company also sells surgical masks, n95 respirators, surgical n95 respirators, and n95 respirators; wound care; urology, incontinence care, and drainage; personal protective equipment; and IV therapy and vascular access. In addition, it offers oral disintegrating strips; and pet pharmaceutical and nutraceutical products and services; and furlife, a mobile application for pets. The company was founded in 1996 and is based in Singapore. Pasture Holdings Ltd. is a subsidiary of PMI Holdings Pte. Ltd.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Pasture Holdings Ltd. reported revenue of 12.2M SGD in FY2025 versus 15.1M SGD in FY2022, a compound −7.0%/yr. Reported net income was 541K SGD in FY2025, compounding −39.6%/yr from FY2022.
Watch UUK: get an alert when its fair value changes →
Peer Group
Medical Distribution · 77 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Distribution median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation MCK | $878.73 | $819.31 | -7% |
| Cencora, Inc COR | $314.17 | $211.07 | -33% |
| Cardinal Health, Inc CAH | $234.16 | $141.77 | -39% |
| Henry Schein, Inc HSIC | $90.74 | $71.70 | -21% |
| Shanghai Pharmaceuticals Holding 601607 | ¥16.56 | ¥33.96 | +105% |
| Sinopharm Group 1099 | HK$16.75 | HK$58.67 | +250% |
| Galenica AG GALE | CHF 80.85 | CHF 61.79 | -24% |
| Guangzhou Baiyunshan Pharmaceutical Holdings 600332 | ¥21.03 | ¥28.65 | +36% |
| Jointown Pharmaceutical Group 600998 | ¥5.04 | ¥9.84 | +95% |
| Asker Healthcare Group ASKER | kr 80.00 | kr 28.26 | -65% |
Compare Pasture Holdings Ltd. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Pasture Holdings Ltd. (UUK) overvalued or undervalued?
What is the fair value of UUK?
What is the quality score of UUK?
What is the revenue of Pasture Holdings Ltd. (UUK)?
What is the net profit margin of UUK?
Does Pasture Holdings Ltd. pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Pasture Holdings Ltd. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.